Division of Pulmonary, Allergy, and Critical Care Medicine and the UAB Lung Health Center, University of Alabama at Birmingham.
Division of General Medicine, Columbia University Medical Center, New York, New York.
JAMA. 2019 Jun 25;321(24):2438-2447. doi: 10.1001/jama.2019.7233.
According to numerous current guidelines, the diagnosis of chronic obstructive pulmonary disease (COPD) requires a ratio of the forced expiratory volume in the first second to the forced vital capacity (FEV1:FVC) of less than 0.70, yet this fixed threshold is based on expert opinion and remains controversial.
To determine the discriminative accuracy of various FEV1:FVC fixed thresholds for predicting COPD-related hospitalization and mortality.
DESIGN, SETTING, AND PARTICIPANTS: The National Heart, Lung, and Blood Institute (NHLBI) Pooled Cohorts Study harmonized and pooled data from 4 US general population-based cohorts (Atherosclerosis Risk in Communities Study; Cardiovascular Health Study; Health, Aging, and Body Composition Study; and Multi-Ethnic Study of Atherosclerosis). Participants aged 45 to 102 years were enrolled from 1987 to 2000 and received follow-up longitudinally through 2016.
Presence of airflow obstruction, which was defined by a baseline FEV1:FVC less than a range of fixed thresholds (0.75 to 0.65) or less than the lower limit of normal as defined by Global Lung Initiative reference equations (LLN).
The primary outcome was a composite of COPD hospitalization and COPD-related mortality, defined by adjudication or administrative criteria. The optimal fixed FEV1:FVC threshold was defined by the best discrimination for these COPD-related events as indexed using the Harrell C statistic from unadjusted Cox proportional hazards models. Differences in C statistics were compared with respect to less than 0.70 and less than LLN thresholds using a nonparametric approach.
Among 24 207 adults in the pooled cohort (mean [SD] age at enrollment, 63 [10.5] years; 12 990 [54%] women; 16 794 [69%] non-Hispanic white; 15 181 [63%] ever smokers), complete follow-up was available for 11 077 (77%) at 15 years. During a median follow-up of 15 years, 3925 participants experienced COPD-related events over 340 757 person-years of follow-up (incidence density rate, 11.5 per 1000 person-years), including 3563 COPD-related hospitalizations and 447 COPD-related deaths. With respect to discrimination of COPD-related events, the optimal fixed threshold (0.71; C statistic for optimal fixed threshold, 0.696) was not significantly different from the 0.70 threshold (difference, 0.001 [95% CI, -0.002 to 0.004]) but was more accurate than the LLN threshold (difference, 0.034 [95% CI, 0.028 to 0.041]). The 0.70 threshold provided optimal discrimination in the subgroup analysis of ever smokers and in adjusted models.
Defining airflow obstruction as FEV1:FVC less than 0.70 provided discrimination of COPD-related hospitalization and mortality that was not significantly different or was more accurate than other fixed thresholds and the LLN. These results support the use of FEV1:FVC less than 0.70 to identify individuals at risk of clinically significant COPD.
根据目前许多指南,慢性阻塞性肺疾病(COPD)的诊断需要第一秒用力呼气量与用力肺活量(FEV1:FVC)的比值小于 0.70,但这个固定阈值是基于专家意见,仍然存在争议。
确定各种 FEV1:FVC 固定阈值对预测 COPD 相关住院和死亡的鉴别准确性。
设计、设置和参与者:美国国立心肺血液研究所(NHLBI)汇集队列研究对来自 4 个美国普通人群队列(社区动脉粥样硬化风险研究;心血管健康研究;健康、衰老和身体成分研究;以及动脉粥样硬化多民族研究)的数据进行了协调和汇集。1987 年至 2000 年期间招募了年龄在 45 岁至 102 岁之间的参与者,并通过 2016 年的纵向随访进行了随访。
气流受限的存在,通过基线 FEV1:FVC 低于一系列固定阈值(0.75 至 0.65)或低于全球肺倡议参考方程(LLN)定义的正常下限来定义。
主要结果是 COPD 住院和 COPD 相关死亡的复合结局,通过裁决或行政标准定义。最佳固定 FEV1:FVC 阈值是通过使用未经调整的 Cox 比例风险模型中的 Harrell C 统计量索引来确定这些 COPD 相关事件的最佳区分度来定义的。使用非参数方法比较了小于 0.70 和小于 LLN 阈值的 C 统计量之间的差异。
在汇集队列中的 24207 名成年人中(入组时的平均[SD]年龄,63[10.5]岁;12990[54%]名女性;16794[69%]名非西班牙裔白人;15181[63%]名曾经吸烟者),在中位随访 15 年期间,11077 名(77%)参与者在 340757 人年的随访中有完整的随访数据。在中位随访 15 年期间,3925 名参与者经历了 COPD 相关事件,共发生 3563 例 COPD 相关住院和 447 例 COPD 相关死亡。在 COPD 相关事件的鉴别方面,最佳固定阈值(0.71;最佳固定阈值的 C 统计量为 0.696)与 0.70 阈值无显著差异(差异,0.001[95%CI,-0.002 至 0.004]),但比 LLN 阈值更准确(差异,0.034[95%CI,0.028 至 0.041])。0.70 阈值在曾经吸烟者的亚组分析和调整后的模型中提供了最佳的鉴别能力。
将气流受限定义为 FEV1:FVC 小于 0.70,可鉴别 COPD 相关住院和死亡,其鉴别能力与其他固定阈值和 LLN 无显著差异或更准确。这些结果支持使用 FEV1:FVC 小于 0.70 来识别有临床意义的 COPD 风险的个体。